Efficacy and safety of Fufang Biejia Ruangan Tablets as an adjuvant treatment for chronic hepatitis B liver fibrosis: A systematic review and meta-analysis

Meta-analysis was used to evaluate the efficacy of Fufang Biejia Ruangan Tablets in the treatment of chronic hepatitis B (CHB) liver fibrosis. METHODS: Databases, including PubMed, China Knowledge Network (CNKI), China Biomedical Database (CBM), Wan Fang, VIP database, Embase, and Cochrane Library w...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Xiangbo, Pan, Zhengqi, Zhao, Jiawei, Feng, Quansheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
4800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678545/
https://www.ncbi.nlm.nih.gov/pubmed/36401442
http://dx.doi.org/10.1097/MD.0000000000031664

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678545/
https://www.ncbi.nlm.nih.gov/pubmed/36401442
http://dx.doi.org/10.1097/MD.0000000000031664

Ejemplares similares